Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Nat Rev Urol. 2016 Mar 8;13(4):205–215. doi: 10.1038/nrurol.2016.45

Table 3.

Published AS cohorts, 2010–2015.

N GS ≥7 (%) Median age (yrs.) Median follow-up (yrs.) Treated (%)
Johns Hopkins 1298 0 66 5.0 36
Sunnybrook 993 13 68 6.4 27
Göteborg 439 NR# 65 6.0 37
UCSF 810 8 62 (mean) 5.0 NR
Royal Marsden 471 7 66 5.7 31
St. Vincent’s 650 14 63 4.6 38
PRIAS 2494 0 66 1.6 21
University of Copenhagen 167 6 65 3.4 35*
University of Miami 230 0 64 3.7 14

NR=Not reported.

#

GS ≥7 not directly reported; 22% of cohort was intermediate risk or higher.

*

Discontinued AS; whether treatment immediately pursued is not disclosed.